Research for my sake, a choice that reaches my descendants
2042The middle futureDeadline · Decision deadline: 30 days, until consent to research participation
A leap assumed
The people, events, figures, and technology in this matter are stated assumptions. They are not to be treated as information about real individuals or as observed events. Background documents are separate sources, and symbolic interpretations are recorded as discovery paths.
The question to decide
In this fictional matter, the somatic cell research aims to improve my life, but it does not change the possibility that the condition will be passed to my descendants. Separate research that could also affect descendants is still under review, and for both paths the effects and long-term impacts are not yet determined. Participate in the somatic cell research, wait for the review of the separate research, or continue present management?
Who decidesAn adult stakeholder considering participation in fictional genetic disease research
What the AI judgments chose
Reading the judgment record…

The options
The order shown is not a ranking of preference.
The situation as it stands
In this world, somatic research and heritable editing research are separated, and for both the actual effects and long-term impacts are undetermined. Decision deadline: 30 days, until consent to research participation.
A fictional issue set in 2042 · Editing that passes to a family and treatment that remains with one person. The people, organizations, figures, and events are a synthetic premise composed for comparison.
- Premise 1In this world, somatic research and heritable editing research are separated, and for both the actual effects and long-term impacts are undetermined.
- Premise 2The somatic route aims to improve the individual's life but does not change the possibility that disease is passed to descendants.
- Premise 3The separate oversight process for the heritable route is not complete, and an expression of willingness to participate is not approval of an actual procedure.
Where it holdsThe individual's research participation and future reproductive choices
What is still unknown
- Unknown 1The independent review status of each route and the conditions for ending participation
- Unknown 2The life goal the stakeholder values most
- Unknown 3The long-term impacts and uncertainties of the changes to be passed to descendants
Signals to decide again
- Decide what observation, responsible party, and confirmation channel can verify "the independent review status of each route and the conditions for ending participation," and re-judge if a new confirmation changes the tradeoffs among the options.
- Decide what observation, responsible party, and confirmation channel can verify "the life goal the stakeholder values most," and re-judge if a new confirmation changes the tradeoffs among the options.
- Decide what observation, responsible party, and confirmation channel can verify "the long-term impacts and uncertainties of the changes to be passed to descendants," and re-judge if a new confirmation changes the tradeoffs among the options.
Where the paths partNot answers — paths that part from the same starting point
The somatic research showed improvement in one target function, but it differed greatly from the participants' life goals.
Independent review judged the data on the intergenerational effects of the heritable research insufficient, and the plan was postponed.
Material and rootsThe frame, the values and the background documents
Do people accept both the benefits of a new capability and the life that capability demands?
An exploratory perspective chosen by the creator. Does not claim supernatural validity or the superiority of any particular option.The benefits and costs of the options accrue to different stakeholders. Which loss to accept remains undecided.
A subject for the decision-maker to argue over; the materials carry no conclusion of their own.- WHO · Human genome editing accessed 2026-09-08
- UNESCO · Universal Declaration on Bioethics and Human Rights 2005-10-19
The record of this question
- Question
FSP-BIOCRAFT-02· version 1.4.0- Content identity, SHA-256
47706e5d3207a2af07c828b8ff80f5b27b01562ff264e18f997aba275917d277- Input files
- Question input JSON · What followed, JSON